Related Experiment Video

Updated: Oct 17, 2026

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

Fluconazole inhibits pseudohyphal growth in Saccharomyces cerevisiae

D P Kontoyiannis1

  • 1Section of Infectious Diseases, Department of Internal Medicine Specialties, The University of Texas M.D. Anderson Cancer Center, Houston, Tex., USA. dkontoyi@notes.mdacc.tmc.edu

Chemotherapy
|February 15, 2000
PubMed

Insights

The antifungal fluconazole inhibits yeast pseudohyphal growth, even at low doses. This finding suggests Saccharomyces cerevisiae can model azole effects in pathogenic fungi like Candida albicans.

Area of Science:

  • Medical Mycology
  • Yeast Genetics

Background:

  • Azole antifungals are crucial for treating fungal infections.
  • Pathogenic yeasts like Candida albicans exhibit morphological changes, such as pseudohyphal growth, which are linked to virulence.
  • Understanding the mechanisms of azole-induced morphogenetic changes is important for developing effective therapies.

Purpose of the Study:

  • To investigate the effect of fluconazole on pseudohyphal growth in Saccharomyces cerevisiae.
  • To determine if Saccharomyces cerevisiae can be used as a model system to study azole-induced morphogenetic effects in pathogenic yeasts.

Main Methods:

  • Utilized Saccharomyces cerevisiae, a genetically tractable yeast species.
  • Administered fluconazole at sub-inhibitory concentrations (not affecting growth).
  • Observed and quantified pseudohyphal growth.

Main Results:

  • Fluconazole significantly inhibited pseudohyphal growth in Saccharomyces cerevisiae at concentrations that did not affect overall cell growth.
  • This inhibition occurred despite fluconazole's primary mechanism of action targeting ergosterol synthesis.

Conclusions:

  • Saccharomyces cerevisiae responds to fluconazole by suppressing pseudohyphal development.
  • The results support the use of Saccharomyces cerevisiae as a model organism to study the morphogenetic impacts of azole antifungals on pathogenic yeasts.

More Related Videos

Automation of Bio-Atomic Force Microscope Measurements on Hundreds of C. albicans Cells09:27

Automation of Bio-Atomic Force Microscope Measurements on Hundreds of C. albicans Cells

Published on: April 2, 2021

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis08:48

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis

Published on: March 19, 2019

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...